N. A. ElSayed, G. Aleppo, V. R. Aroda, et al: American Diabetes Association. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2023. In: Diabetes Care. 46(Suppl. 1), 2023, S.203–215, doi:10.2337/dc23-S012.
M. Abràmoff et al.:
Automated and Computer-Assisted Detection, Classification, and Diagnosis of Diabetic Retinopathy. In: Telemed. J. E-Health. Band 26, Nr. 4, 2020, S. 544–550. doi:10.1089/tmj.2020.0008
nih.gov
ncbi.nlm.nih.gov
D. Kook, A. Wolf, T. Kreutzer u. a.: Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. In: Retina. Band 28, Nr. 8, Okt 2008, S. 1053–1060. PMID 18779710
J. F. Arevalo, R. A. Garcia-Amaris: Intravitreal bevacizumab for diabetic retinopathy. In: Curr Diabetes Rev. Band 5, Nr. 1, Feb 2009, S. 39–46. PMID 19199897
G. P. Giuliari, D. A. Guel, V. H. Gonzalez: Pegaptanib sodium for the treatment of proliferative diabetic retinopathy and diabetic macular edema. In: Curr Diabetes Rev. Band 5, Nr. 1, Feb 2009, S. 33–38. PMID 19199896